KRHIS

Here is a listing of nationwide funding opportunities that may be of interest to you:

 

KUSM-Wichita

The University of Kansas School of Medicine – Wichita (KUSM- Wichita) seeks family physician faculty for medical student and residency education.

• An average of 25% of KUSM – Wichita medical students enter family medicine residency positions each year.
• Top 10 ranking in GME outcomes for primary care, rural practice and HPSA practice (Academic Medicine 2013;88:1267–1280).
• Outstanding medical students, residents and faculty colleagues.
• KUSM-Wichita is recognized for outstanding clinical teaching.
• New medical school curriculum emphasizes small group problem-based learning and early clinical experiences.
• Campus expansion offers a wide variety of teaching opportunities.
• Excellent salary and benefit package.

To apply on-line:

For more information, contact Rick Kellerman MD, Professor and Chair, Department of Family and Community Medicine, KUSM-Wichita, rkellerm@kumc.edu or 316-293-2607, 1010 North Kansas, Wichita, KS, 67214.

KU Medical Center is an Equal Opportunity/Affirmative Action employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, protected veteran or disability status, or genetic information.

American Cancer Society

The death rate from cancer in the U.S. has declined steadily over the past 25 years, according to annual statistics reporting from the American Cancer Society. As of 2016, the cancer death rate for men and women combined had fallen 27 percent from its peak in 1991. This decline translates to about 1.5 percent per year and more than 2.6 million deaths avoided between 1991 and 2016.

The drop in cancer mortality is mostly due to steady reductions in smoking and advances in early detection and treatment. But not all populations are benefiting. Although the racial gap in cancer deaths is slowly narrowing, socioeconomic inequalities are widening. “Cancer Statistics, 2019,” published in the American Cancer Society’s journal CA: A Cancer Journal for Clinicians, estimates the numbers of new cancer cases and deaths expected in the U.S. this year. The estimates are some of the most widely quoted cancer statistics in the world. The information is also released in a companion report, Cancer Facts and Figures 2019, available on the interactive website, the Cancer Statistics Center.

A total of 1,762,450 new cancer cases and 606,880 deaths from cancer are expected to occur in the U.S. in 2019. During the most recent decade of available data (2006 – 2015), the rate of new cancer diagnoses decreased by about 2 percent per year in men and stayed about the same in women. The cancer death rate (2007 – 2016) declined by 1.4 percent per year in women and 1.8 percent per year in men.

NAMI

Attention KanCare providers: The information card explaining the expanded KanCare benefits for tobacco cessation has been updated to include 2019 KanCare MCOs. Thank you for your continued partnership in providing this information to your patients. Please print the information cards in-house or contact Kim Neufeld to request a quantity of the printed cards. Download 2019 KanCare Tobacco Cessation Card.

One Health Commission

The One Health Academy, Washington DC presents Dennis Carroll, PhD, who currently serves as the director of the U.S. Agency for International Development’s (USAID’s) Global Health Security and Development Unit.

The Future is Coming! Is One Health Ready?
Wednesday, January 9
5:45 p.m.
Registration is free but registration is required for login.

Dr. Carroll is responsible for providing strategic and operational leadership for the agency’s programs addressing new and emerging disease threats. Dr. Carroll also serves as USAID’s special representative for global health security. Dr. Carroll was initially detailed to USAID from the U.S. Centers for Disease Control and Prevention (CDC) as a senior public health advisor in 1991. In 1995 he was named the agency’s senior infectious diseases advisor, responsible for overseeing the agency’s programs in malaria, tuberculosis, antimicrobial resistance, disease surveillance, as well as neglected and emerging infectious diseases. In this capacity Dr. Carroll was directly involved in the development and introduction of a range of new technologies for disease prevention and control, including: community-based delivery of treatment of onchocerciasis, rapid diagnostics for malaria, new treatment therapies for drug-resistant malaria, intermittent therapy for pregnant women, and “long-lasting” insecticide treated bed nets for prevention of malaria. He was responsible for the initial design and development of the President’s Malaria Initiative. Dr. Carroll officially left CDC and joined USAID in 2005 when he assumed responsibility for leading the USAID response to the spread of avian influenza.

Dr. Carroll has a doctorate in biomedical research with a special focus in tropical infectious diseases from the University of Massachusetts at Amherst. He was a research scientist at Cold Spring Harbor Laboratory where he studied the molecular mechanics of viral infection. Dr. Carroll has received awards from both CDC and USAID, including the 2006 USAID Science and Technology Award for his work on malaria and avian influenza, and the 2008 Administrator’s Management Innovation Award for his management of the agency’s Avian and Pandemic Influenza program.